Food Insecurity Increases Risk for Binge Eating Disorder and Obesity
Investigators observed a link between food insecurity — difficulty affording enough food to support regular, balanced meals — and increased probability of binge-eating disorder and obesity, according to study results.
Aripiprazole, Bupropion Augmentation More Cost-Effective Than Just Bupropion
Investigators evaluated the cost-effectiveness of augmentation with either aripiprazole or bupropion in patients with depression compared with switching to a new antidepressant.
Valbenazine May Improve Movement Disorders in Patients With Mood Disorders
An analysis of once-daily valbenazine trials revealed improvements in tardive dyskinesia in patients with mood disorders.
Ketamine May Be Equally Effective in Anxious vs Nonanxious Depression
Researchers found that there is a potential for the use of intravenous ketamine for anxious treatment-resistant depression.
FDA: Important Updates to the Clozapine REMS Program
Products covered under the Clozapine REMS program include Clozaril (HLS Therapeutics), Fazaclo (Jazz), and Versacloz (TruPharma), in addition to all generic versions.
Smoking Associated With Worsened Symptoms, Quality of Life in Patients With Psychosis
A negative association between number of cigarettes per day and quality of life was observed in patients with psychosis.
Insomnia Increases Emotional Dysregulation, Impulsivity, and Suicidality in Bipolar Disorder
Sleep has important functions for the regulation of mood and emotion, and treatment of sleep disturbances in bipolar disorder may improve patient outcomes.
NDA Submitted for Novel Insomnia Treatment Lemborexant
The NDA includes data from two Phase 3 clinical trials (SUNRISE 1 and SUNRISE 2) which included approximately 2000 patients.
How the Government Shutdown Affects FDA Activities
The consequence of the shutdown means the budget appropriated by Congress for the Agency is on hold, resulting in ~7000 of it’s 17,000 employees being furloughed.
The Robot Will See You Now: The Increasing Role of Robotics in Psychiatric Care
Dr Pransky shares some examples of robots that have shown impressive psychiatric applications, as well as her thoughts on giving robots the critical role of delivering healthcare to human beings.
Extended-Release Naltrexone Improves Psychiatric Disorders During Addiction Therapy
Changes in anxiety, depression, or insomnia symptoms were examined in patients with opioid use disorder taking extended-release naltrexone or buprenorphine-naloxone.
Infections, Antibiotics Associated With Subsequent Increased Risk for Mental Disorders in Youth
The risk for mental disorders increased after severe infections requiring hospitalizations in children.
Nonmedical Prescription Opioid Use Motivated by Pain Relief in Adolescence Predicts Later SUD
A set of characteristics of nonmedical use of prescription opioids in adolescents may help identify youth at high risk for substance use disorder, including opioid misuse, in early midlife.
Pregnancy Reduces the Risk for Alcohol Use Disorder Among Women and Their Partners
Despite the reduction in the ability to exercise free will associated with substance use disorders and the severity of these disorders, pregnancy appears to have protective effects.